< Major Announcements After Market Close >
◆Codiem=Announced that the CEO will change from Moon Yong-bae to Hwang Jeong-hoon.
◆Kainosmed=Announced the establishment of a U.S. subsidiary (FAScinate Therapeutics, Inc.) to conduct clinical trials in the U.S. for Parkinson's disease treatments and others.
◆Celltrion Pharm=Announced that it borrowed funds from the Korea Development Bank and received collateral from Celltrion Holdings. The collateral amount is 20 billion KRW.
◆S-Energy=Announced the decision to dispose of 238,060 shares of its subsidiary S-Fuel Cell for approximately 9.5 billion KRW. After disposal, the shareholding ratio will be 33.42%.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
◆Kolon Life Science=Announced the sale of land and buildings of Kolon One & Only Tower in Gangseo-gu, Seoul for 29.345 billion KRW to improve financial structure efficiency.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
